Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1981 November; 68(5): 1289–1294.
PMCID: PMC370924

Hemostatic Function, Survival, and Membrane Glycoprotein Changes in Young versus Old Rabbit Platelets


Although in vitro studies have demonstrated functional differences between young and old platelets, in vivo differences have not been precisely established. Therefore the in vivo hemostatic function of young and old platelets and the survival time have been examined in rabbits. The hemostatic function was measured by performing serial ear bleeding times in irradiation-induced thrombocytopenic rabbits. After irradiation with 930 rad the platelet count gradually diminished reaching a nadir (~20 × 103/μl) at 10 d. The platelets present in the circulation, 7-10 d after irradiation, were considered old platelets, and the platelets present after recovery, 11-14 d postirradiation, young platelets. The measurement of platelet size was consistent with the hypothesis that platelets become smaller with age: the mean size was 3.84 μm3 for old platelets and 5.86 μm3 for young platelets. Regression analysis of the relationship between the bleeding time and the platelet count in 18 rabbits showed a significantly different slope for rabbits with predominantly old platelets compared with rabbits with predominantly young platelets (P < 0.001). Young platelets were more effective giving much shorter bleeding times than old platelets at comparable platelet counts. Survival times of young and old platelets were measured using platelets harvested on day 8 postirradiation (old platelets) and day 12 postirradiation (young platelets) that were labeled and then reinjected into normal recipient animals. The mean platelet survival time, calculated by gamma function, of old platelets was 28.8 h; of young platelets, 87.4 h; and of normally circulating heterogeneous platelets, (normal platelets) 53.0 h. Notably, the survival of old platelets was found to be exponential, and of young platelets, linear. Analysis of the membrane glycoproteins in young, old and normal platelets indicated that there was no qualitative difference amongst the young, normal, and old platelets. The relative relationship among all the glycoprotein peaks was equal and the only changes observed were quantitative, with young platelets having significantly more membrane glycoprotein per cell than old platelets and normal platelets. Normal platelets had intermediate concentrations of each glycoprotein. These results demonstrate that young platelets are hemostatically more effective in vivo than old platelets. The data are compatible with the hypothesis that platelets age in the circulation by losing membrane fragments and then after becoming senescent, are removed from the circulation by a random process.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • DETWILER TC, ODELL TT, Jr, MacDONALD TP. Platelet size, ATP content, and clot retraction in relation to platelet age. Am J Physiol. 1962 Jul;203:107–110. [PubMed]
  • Booyse FM, Hoveke TP, Rafelson ME., Jr Studies on human platelets. II. Protein synthetic activity of various platelet populations. Biochim Biophys Acta. 1968 May 21;157(3):660–663. [PubMed]
  • Hirsh J, Glynn MF, Mustard JF. The effect of platelet age on platelet adherence to collagen. J Clin Invest. 1968 Mar;47(3):466–473. [PMC free article] [PubMed]
  • Karpatkin S. Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest. 1969 Jun;48(6):1073–1082. [PMC free article] [PubMed]
  • Karpatkin S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest. 1969 Jun;48(6):1083–1087. [PMC free article] [PubMed]
  • Okuma M, Steiner M, Baldini M. Lipid peroxidation in aging platelets. Blood. 1969 Nov;34(5):712–716. [PubMed]
  • Shulman NR, Watkins SP, Jr, Itscoitz SB, Students AB. Evidence that the spleen retains the youngest and hemostatically most effective platelets. Trans Assoc Am Physicians. 1968;81:302–313. [PubMed]
  • Steiner M, Baldini M. Protein synthesis in aging blood platelets. Blood. 1969 Apr;33(4):628–633. [PubMed]
  • Karpatkin S, Charmatz A. Hetrogeneity of human platelets. 3. Glycogen metabolism in platelets of different sizes. Br J Haematol. 1970 Aug;19(2):135–143. [PubMed]
  • Ginsburg AD, Aster RH. Changes associated with platelet aging. Thromb Diath Haemorrh. 1972 Jul 31;27(3):407–415. [PubMed]
  • Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med. 1972 Jul 27;287(4):155–159. [PubMed]
  • Karpatkin S, Strick N. Heterogeneity of human platelets. V. Differences in glycolytic and related enzymes with possible relation to platelet age. J Clin Invest. 1972 May;51(5):1235–1243. [PMC free article] [PubMed]
  • Charmatz A, Karpatkin S. Heterogeneity of rabbit platelets. I. Employment of an albumin density gradient for separation of a young platelet population identified with se75-selenomethionine. Thromb Diath Haemorrh. 1974 Jun 30;31(3):485–492. [PubMed]
  • Penington DG, Lee NL, Roxburgh AE, McGready JR. Platelet density and size: the interpretation of heterogeneity. Br J Haematol. 1976 Nov;34(3):365–376. [PubMed]
  • Penington DG, Streatfield K, Roxburgh AE. Megakaryocytes and the heterogeneity of circulating platelets. Br J Haematol. 1976 Dec;34(4):639–653. [PubMed]
  • Corash L, Tan H, Gralnick HR. Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood. 1977 Jan;49(1):71–87. [PubMed]
  • Corash L, Shafer B, Perlow M. Heterogeneity of human whole blood platelet subpopulations. II. Use of a subhuman primate model to analyze the relationship between density and platelet age. Blood. 1978 Oct;52(4):726–734. [PubMed]
  • Friedhoff AJ, Miller JC, Karpatkin S. Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density. Blood. 1978 Feb;51(2):317–323. [PubMed]
  • Karpatkin S. Heterogeneity of rabbit platelets. VI. Further resolution of changes in platelet density, volume, and radioactivity following cohort labelling with 75Se-selenomethione. Br J Haematol. 1978 Jul;39(3):459–469. [PubMed]
  • Karpatkin S, Khan Q, Freedman M. Heterogeneity of platelet function. Correlation with platelet volume. Am J Med. 1978 Apr;64(4):542–546. [PubMed]
  • Murphy DL, Costa JL, Shafer B, Corash L. Monoamine oxidase activity in different density gradient fractions of human platelets. Psychopharmacology (Berl) 1978 Oct 31;59(2):193–197. [PubMed]
  • Corash L. Platelet heterogeneity. Psychopharmacol Bull. 1980 Jan;16(1):65–67. [PubMed]
  • Blajchman MA, Senyi AF, Hirsh J, Surya Y, Buchanan M, Mustard JF. Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall. J Clin Invest. 1979 May;63(5):1026–1035. [PMC free article] [PubMed]
  • BRECHER G, CRONKITE EP. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. [PubMed]
  • Murphy EA, Francis ME. The estimation of blood platelet survival. II. The multiple hit model. Thromb Diath Haemorrh. 1971;25(1):53–80. [PubMed]
  • George JN. Studies on platelet plasma membranes. IV. Quantitative analysis of platelet membrane glycoproteins by (125I)-diazotized diiodosulfanilic acid labeling and SDS-polyacrylamide gel electrophoresis. J Lab Clin Med. 1978 Sep;92(3):430–446. [PubMed]
  • George JN, Lewis PC, Sears DA. Studies on platelet plasma membranes. II. Characterization of surface proteins of rabbit platelets in vitro and during circulation in vivo using diazotized (125i)-diiodosulfanilic acid as a label. J Lab Clin Med. 1976 Aug;88(2):247–260. [PubMed]
  • Ginsburg AD, Aster RH. Kinetic studies with 51-chromium-labeled platelet cohorts in rats. J Lab Clin Med. 1969 Jul;74(1):138–144. [PubMed]
  • George JN, Lewis PC. Studies on platelet plasma membranes. III. Membrane glycoprotein loss from circulating platelets in rabbits: inhibition by aspirin-dipyridamole and acceleration by thrombin. J Lab Clin Med. 1978 Feb;91(2):301–306. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation